Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11172224 | 0.87 | KDM4E (0.47) | ALDH1A1KDM4EGAASMN1; SMN2NPSR1 | |
| SCHEMBL5099 | 0.79 | MAOA (0.48) | ALDH1A1KDM4EGAASMN1; SMN2KMT2A | |
| SCHEMBL654268 | 0.77 | MAOA (0.63) | ALDH1A1KDM4EGAASMN1; SMN2KMT2A | |
| SCHEMBL29709713 | 0.74 | KMT2A (0.62) | ALDH1A1KDM4EGAASMN1; SMN2NPSR1 | |
| SCHEMBL304367 | 0.74 | KMT2A (0.62) | ALDH1A1KDM4EGAASMN1; SMN2NPSR1 | |
| SCHEMBL29416517 | 0.74 | KMT2A (0.62) | ALDH1A1KDM4EGAASMN1; SMN2NPSR1 | |
| SCHEMBL10507038 | 0.74 | SMN1; SMN2 (0.53) | ALDH1A1KDM4EGAASMN1; SMN2NPSR1 | |
| SCHEMBL2409495 | 0.73 | CYP2A6 (0.33) | ALDH1A1SMN1; SMN2TDP1HSD17B10CYP3A4 | |
| Water SCHEMBL28602073 | 0.73 | KMT2A (0.60) | ALDH1A1KDM4EGAASMN1; SMN2NPSR1 | |
| SCHEMBL10025828 | 0.73 | L3MBTL1 (0.60) | ALDH1A1KDM4EGAASMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 331 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1658081-A2 | IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | 4 AZA Bioscience nv (BE) | 2006-05-24 | — | — | EP | claimed |
| WO-2005021003-A2 | IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | 4 AZA BIOSCIENCE NV (BE) | 2005-03-10 | — | — | WO | claimed |
| US-20040077859-A1 | Immunosuppressive effects of pteridine derivatives | 4 AZA BIOSCIENCE NV (BE) | 2004-04-22 | — | — | US | claimed |
| US-5554735-A | Azo oxime ethers and their use as fungicides | CIBA-GEIGY CORPORATION (US) | 1996-09-10 | — | — | US | claimed |
| EP-0628027-A1 | AZO OXIME ETHERS AND THEIR USE AS FUNGICIDES | CIBA-GEIGY AG (CH) | 1994-12-14 | — | — | EP | claimed |
| WO-1993016986-A1 | AZO OXIME ETHERS AND THEIR USE AS FUNGICIDES | CIBA-GEIGY AG (CH) | 1993-09-02 | — | — | WO | claimed |
| US-5216146-A | 2-benzocoumarinyl-carbapenems | MERCK & CO., INC. (US) | 1993-06-01 | — | — | US | claimed |
| EP-0515232-A1 | 2-benzocoumarinyl-carbapenems | MERCK & CO. INC. (US) | 1992-11-25 | — | — | EP | claimed |
| US-20240231224-A9 | HALOGEN-AND ALIPHATIC-CONTAINING ORGANOTIN PHOTORESISTS AND METHODS THEREOF | LAM RESEARCH CORPORATION | 2024-07-11 | — | — | US | disclosed |
| WO-2024137876-A2 | SURFACE MODIFICATION OF METAL CATALYSTS WITH HYDROPHOBIC LIGANDS OR IONOMERS | TWELVE BENEFIT CORPORATION (US) | 2024-06-27 | — | — | WO | disclosed |
| US-20240200208-A1 | CO2 PURIFICATION AND REDUCTION SYSTEMS | SUMITOMO MITSUI BANKING CORPORATION | 2024-06-20 | — | — | US | disclosed |
| WO-2024123514-A1 | CO2 PURIFICATION AND REDUCTION SYSTEMS | TWELVE BENEFIT CORPORATION (US) | 2024-06-13 | — | — | WO | disclosed |
| US-20240192590-A1 | APPARATUS AND PROCESS FOR EUV DRY RESIST SENSITIZATION BY GAS PHASE INFUSION OF A SENSITIZER | LAM RESEARCH CORPORATION | 2024-06-13 | — | — | US | disclosed |
| WO-2024108304-A1 | DITHIOL CHELATORS FOR METAL CONJUGATION TO ANTIBODIES | STANDARD BIOTOOLS CANADA INC. (CA) | 2024-05-30 | — | — | WO | disclosed |
| US-5216146-A | 2-benzocoumarinyl-carbapenems | MERCK & CO., INC. (US) | 1993-06-01 | — | — | US | disclosed |
| US-5182384-A | Chemical intermediates for bactericides | MERCK & CO., INC. (US) | 1993-01-26 | — | — | US | disclosed |
| EP-0515232-A1 | 2-benzocoumarinyl-carbapenems | MERCK & CO. INC. (US) | 1992-11-25 | — | — | EP | disclosed |
| EP-0515217-A1 | 2-Benzocoumarinyl carbapenems | MERCK & CO. INC. (US) | 1992-11-25 | — | — | EP | disclosed |
| US-5162314-A | 2-benzocoumarinyl carbapenems | MERCK & CO., INC. (US) | 1992-11-10 | — | — | US | disclosed |
| US-5153186-A | Antibiotics for methicillin resistant Staphylococcus strains | MERCK & CO., INC. (US) | 1992-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077859-A1 | Immunosuppressive effects of pteridine derivatives | TPMT, NFATC1, MALT1 | ALDH1A1 1257/4885KDM4E 2108/4885GAA 3811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.